Stoneridge and Its Impact on European Capital Market and Consumer Law – Is There a Sanction for Aiding and Abetting a False or Misleading Financial Statement in European Capital Market Law? –
-
Mark C. Hilgard
The recent decision Stoneridge Investment Partners, LLC v. Scientific Atlanta, Inc. of the U.S. Supreme Court was even before it was published exposed to a severe debate about the future of the regulation of security fraud under Sec. 10 (b) Securities Exchange Act. Especially outside of the United States it was feared that a broad interpretation of the U.S. Supreme Court would lead to a de facto worldwide application of Sec. 10 (b) Securities Exchange Act which would have had a severe impact especially on transatlantic business relations. Whereas the case and the decision was so far mainly discussed from an American perspective the following case note will examine the very same question under European capital market law and its impact on the discussion in Europe on the introduction of a European style class action.
© Copyright 2008 by the European Company and Financial Law Review (ECFR)
Articles in the same Issue
- Standardization of Company Law in Germany, other EU Member States and Turkey by Corporate Governance Rules
- The National Implementation of Employee Participation in the Administrative Board of the SE in the One-tier Model – A Legal Comparison on the Basis of Germany, Austria, Sweden, and France –
- Stoneridge and Its Impact on European Capital Market and Consumer Law – Is There a Sanction for Aiding and Abetting a False or Misleading Financial Statement in European Capital Market Law? –
Articles in the same Issue
- Standardization of Company Law in Germany, other EU Member States and Turkey by Corporate Governance Rules
- The National Implementation of Employee Participation in the Administrative Board of the SE in the One-tier Model – A Legal Comparison on the Basis of Germany, Austria, Sweden, and France –
- Stoneridge and Its Impact on European Capital Market and Consumer Law – Is There a Sanction for Aiding and Abetting a False or Misleading Financial Statement in European Capital Market Law? –